SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Hippieslayer who wrote (14922)2/12/1998 7:30:00 PM
From: Henry Niman  Read Replies (2) | Respond to of 32384
 
Fugazi, How about throwing in an asthma story (novel treatment with IL-4 antagonist), TSE424 for osteoporosis, and positive clinicals for prostate and ovarian cancer? Sooner or later the lights will turn on (and its already later).



To: Hippieslayer who wrote (14922)2/12/1998 7:33:00 PM
From: RXGOLF  Respond to of 32384
 
Fugazi,
Maybe I was just dreaming for a little press.But with breast cancer affecting so many, and available treatments being so limited, I figure this will spark the interest of many if they are exposed to Ligands results.
PS: I considered giving this to you privately so nobody would see me responding to you. I think you are making lots of new friends here.(:>)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News